This study investigates the effects of an investigational medication on adults with moderate to severe Crohn's Disease. The purpose is to evaluate the safety and effectiveness of different doses compared to a placebo. Participants will be in the study for up to 59 weeks, including a 4-week screening period, 52 …
This study investigates the efficacy and safety of an investigational medication in adults with moderate-to-severe ulcerative colitis. Participants will be in the study for up to 59 weeks, including a 28-day screening period, a 52-week main treatment period, and a 2-week follow-up. The main treatment period consists of a 12-week …
This study investigates the safety and efficacy of an investigational antibody in protecting against Respiratory Syncytial Virus (RSV) in young children. This study involves neonates and infants aged 0 to 12 months, as well as children up to 24 months of age who are vulnerable to severe RSV disease.Participants will …
This study investigates the long-term safety and efficacy of an investigational medication in adults with asthma. It is an extension of previous studies and will last up to 100 weeks, with participants receiving treatment for up to 96 weeks. The purpose of this study is to continue monitoring the effects …
This study investigates the safety and effectiveness of an investigational medication for people aged 12 and older with moderate to severe atopic dermatitis. Participants will be involved in the study for up to 284 weeks. This includes a screening period lasting 2 to 4 weeks, a treatment period of up …
The purpose of this study is to investigate the long-term effects of an investigational medication on preventing lung function decline in adults with uncontrolled moderate to severe asthma. The study will last for a total of 3 years, following a screening and run-in period of about 4 weeks. Participants will …
This study investigates the effects of an investigational medication compared to a daily oral dose of another treatment in adults with relapsing forms of multiple sclerosis. The study will last at least 12 months for the last participant and could be up to 40 months or longer for the first …
This study investigates the clinical outcomes of patients with Gaucher disease. The study is observational, meaning it collects data from patients receiving routine care without altering their treatment. It aims to enhance understanding of the disease's variability, progression, and natural history to aid in better therapeutic interventions.Participants will undergo clinical …
This study investigates Pompe disease, focusing on muscle function impacts due to glycogen buildup. The purpose of this observational study is to track the natural history and outcomes of Pompe disease in patients worldwide, regardless of treatment status. An observational study involves collecting data by observing participants receiving routine care, …
This study investigates Fabry disease, focusing on tracking the routine clinical outcomes for patients, regardless of their treatment status. The study is observational, meaning it collects data by observing participants without altering their treatment. Participants will be in the study for an ongoing period as determined by their physician.Participants in …
